Centene/$CNC
1D1W1MYTD1Y5YMAX
Capital at risk
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
- Ticker
- $CNC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 61,100
- Headquarters
- Saint Louis, United States
- Website
- www.centene.com
Centene Metrics
BasicAdvanced
$34B
-
-$10.36
1.08
-
Price and volume
Market cap
$34B
Beta
1.08
52-week high
$69.63
52-week low
$31.63
Average daily volume
4.1M
Financial strength
Current ratio
1.145
Quick ratio
1.106
Long term debt to equity
0.708
Total debt to equity
0.711
Interest coverage (TTM)
5.13%
Profitability
EBITDA (TTM)
4,616
Gross margin (TTM)
11.41%
Net profit margin (TTM)
-2.83%
Operating margin (TTM)
1.87%
Effective tax rate (TTM)
-10.23%
Revenue per employee (TTM)
$2,950,000
Management effectiveness
Return on assets (TTM)
2.49%
Return on equity (TTM)
-20.36%
Valuation
Price to revenue (TTM)
0.189
Price to book
1.52
Price to tangible book (TTM)
4.56
Price to free cash flow (TTM)
3.816
Free cash flow yield (TTM)
26.20%
Free cash flow per share (TTM)
18.188
Growth
Revenue change (TTM)
12.94%
Earnings per share change (TTM)
-354.74%
3-year revenue growth (CAGR)
9.30%
10-year revenue growth (CAGR)
20.45%
3-year earnings per share growth (CAGR)
29.04%
10-year earnings per share growth (CAGR)
23.12%
What the Analysts think about Centene
Analyst ratings (Buy, Hold, Sell) for Centene stock.
Analyst projections of the future price of Centene stock.
Bulls say / Bears say
On July 28, Centene raised its annual profit and revenue forecasts after beating quarterly earnings estimates, underscoring robust cost control and operational strength. (Reuters)
The company's Q2 health benefit ratios improved significantly, with Commercial HBR at 79.2%, Medicare HBR at 89.5%, and Medicaid HBR at 93.9%, reflecting enhanced profitability across segments. (PR Newswire)
Chris Neczypor, formerly CFO of Lincoln Financial, will join as Centene’s CFO in January 2027, bringing strategic finance expertise expected to drive efficiency and shareholder value. (Reuters)
Centene warned on July 28 of an 8–9% decline in its Medicaid membership, leaving a sicker patient population and contributing to a nearly 6% drop in its share price. (Reuters)
The company is offering staff buyouts after steep losses in its Obamacare memberships, highlighting enrollment headwinds and uncertainty around 2026 plan participation. (Reuters)
A February subpoena by a U.S. House Judiciary Committee probing potential fraud in ACA subsidies places Centene under regulatory scrutiny and potential compliance costs. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 24 Aug 2026.
Centene Financial Performance
Revenues and expenses
Centene Earnings Performance
Company profitability
Upcoming events
No upcoming events
Centene News
AllArticlesVideos
Funds containing Centene
AllEURUSDGBP
Fund name | Fund size | $CNC weighting |
|---|---|---|
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.49% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 0.41% |
iShares Edge MSCI World Value Factor$IWVL | $7.4B | 0.22% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.22% |
iShares Edge MSCI World Value Factor€IS3S | €6.4B | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.